FibroBiologics, Inc. Common StockFBLGNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-16.66M
↓ 136% vs avg
Percentile
P0
Near historical low
Streak
5 yr
Consecutive declineContracting
Average
$-7.05M
Historical baseline
PeriodValueYoY Change
TTM$-16.66M-37.8%
2024$-12.09M-75.2%
2023$-6.90M-69.6%
2022$-4.07M-188.4%
2021$-1.41M-20.6%
2020$-1.17M-